23ME610 by 23AndMe Holding for Merkel Cell Carcinoma: Likelihood of Approval

23ME610 is under clinical development by 23andMe Holding and currently in Phase II for Merkel Cell Carcinoma.

Source link
#23ME610 #23AndMe #Holding #Merkel #Cell #Carcinoma #Likelihood #Approval